196 related articles for article (PubMed ID: 24158745)
1. Novel anti-plasmodial hits identified by virtual screening of the ZINC database.
Mugumbate G; Newton AS; Rosenthal PJ; Gut J; Moreira R; Chibale K; Guedes RC
J Comput Aided Mol Des; 2013 Oct; 27(10):859-71. PubMed ID: 24158745
[TBL] [Abstract][Full Text] [Related]
2. Cysteine proteases of malaria parasites.
Rosenthal PJ
Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
[TBL] [Abstract][Full Text] [Related]
3. Falcipains and other cysteine proteases of malaria parasites.
Rosenthal PJ
Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
[TBL] [Abstract][Full Text] [Related]
4. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
Kesharwani RK; Singh DV; Misra K
J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
[TBL] [Abstract][Full Text] [Related]
5. Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.
Teixeira C; Gomes JR; Gomes P
Curr Med Chem; 2011; 18(10):1555-72. PubMed ID: 21428877
[TBL] [Abstract][Full Text] [Related]
6. The impact of whole genome sequence data on drug discovery--a malaria case study.
Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
[TBL] [Abstract][Full Text] [Related]
7. Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures.
Hernández-González JE; Salas-Sarduy E; Hernández Ramírez LF; Pascual MJ; Álvarez DE; Pabón A; Leite VBP; Pascutti PG; Valiente PA
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2911-2923. PubMed ID: 30253205
[TBL] [Abstract][Full Text] [Related]
8. Selection of cysteine protease inhibitor-resistant malaria parasites is accompanied by amplification of falcipain genes and alteration in inhibitor transport.
Singh A; Rosenthal PJ
J Biol Chem; 2004 Aug; 279(34):35236-41. PubMed ID: 15192087
[TBL] [Abstract][Full Text] [Related]
9. Cysteine proteases of malaria parasites: targets for chemotherapy.
Rosenthal PJ; Sijwali PS; Singh A; Shenai BR
Curr Pharm Des; 2002; 8(18):1659-72. PubMed ID: 12132997
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.
Subramanian S; Hardt M; Choe Y; Niles RK; Johansen EB; Legac J; Gut J; Kerr ID; Craik CS; Rosenthal PJ
PLoS One; 2009; 4(4):e5156. PubMed ID: 19357776
[TBL] [Abstract][Full Text] [Related]
11. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
Moura PA; Dame JB; Fidock DA
Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
[TBL] [Abstract][Full Text] [Related]
12. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
[TBL] [Abstract][Full Text] [Related]
13. Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012).
Pérez B; Teixeira C; Gomes JR; Gomes P
Curr Med Chem; 2013; 20(25):3049-68. PubMed ID: 23514416
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library.
Shah F; Mukherjee P; Gut J; Legac J; Rosenthal PJ; Tekwani BL; Avery MA
J Chem Inf Model; 2011 Apr; 51(4):852-64. PubMed ID: 21428453
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M
J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575
[TBL] [Abstract][Full Text] [Related]
16. An endoperoxide-based hybrid approach to deliver falcipain inhibitors inside malaria parasites.
Oliveira R; Newton AS; Guedes RC; Miranda D; Amewu RK; Srivastava A; Gut J; Rosenthal PJ; O'Neill PM; Ward SA; Lopes F; Moreira R
ChemMedChem; 2013 Sep; 8(9):1528-36. PubMed ID: 23853126
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
Singh A; Rosenthal PJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
[TBL] [Abstract][Full Text] [Related]
18. Falcipain inhibition as a promising antimalarial target.
Marco M; Coterón JM
Curr Top Med Chem; 2012; 12(5):408-44. PubMed ID: 22242849
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial activities of novel synthetic cysteine protease inhibitors.
Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial synergy of cysteine and aspartic protease inhibitors.
Semenov A; Olson JE; Rosenthal PJ
Antimicrob Agents Chemother; 1998 Sep; 42(9):2254-8. PubMed ID: 9736544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
